LOL, hopefully another fund is going to make a proxy run at Denner... that'll be fun to watch. Or hire Robbins Geller Rudman and Dowd, LLP and sue. They know how to handle Denner.
Nice. About time someone publicly called out Sarissa for their intentional incompetence.
Be nice to figure out which investors they represent. I don't see JEC anywhere on the 13f report, so I assume they are investors in their own accounts/funds.
JEC has done this same maneuver with several other biotechs: Atea Carisma Sesen